- 5 Ergebnisse
Kleinster Preis: € 14,10, größter Preis: € 143,27, Mittelwert: € 83,57
1
Antianginal Drugs : Pathophysiological, Haemodynamic, Methodological, Pharmacological, Biochemical and Clinical Basis for Their Use in Human Therapeutics - Robert Charlier
Bestellen
bei ZVAB.com
€ 106,72
Versand: € 0,001
Bestellen
Details beim Anbieter
gesponserter Link
Robert Charlier:

Antianginal Drugs : Pathophysiological, Haemodynamic, Methodological, Pharmacological, Biochemical and Clinical Basis for Their Use in Human Therapeutics - Taschenbuch

2011, ISBN: 3642651674

[EAN: 9783642651670], Neubuch, [SC: 0.0], [PU: Springer Berlin Heidelberg], DRUG; HEART; PATHOLOGY; RESEARCH, Druck auf Anfrage Neuware -If the numerous therapeutic acquisitions of the pa… Mehr…

NEW BOOK. Versandkosten:Versandkostenfrei. (EUR 0.00) AHA-BUCH GmbH, Einbeck, Germany [51283250] [Rating: 5 (von 5)]
zuklappen (X)
2
Antianginal Drugs: Pathophysiological, Haemodynamic, Methodological, Pharmacological, Biochemical and Clinical Basis for Their Use in Human ... of Experimental Pharmacology (31), Band 31) - Charlier, Robert
Bestellen
bei amazon.de
€ 143,27
Versand: € 3,001
Bestellen
Details beim Anbieter
gesponserter Link

Charlier, Robert:

Antianginal Drugs: Pathophysiological, Haemodynamic, Methodological, Pharmacological, Biochemical and Clinical Basis for Their Use in Human ... of Experimental Pharmacology (31), Band 31) - Taschenbuch

1971, ISBN: 9783642651670

Springer-Verlag, Taschenbuch, Auflage: Softcover reprint of the original 1st ed. 1971, 456 Seiten, Publiziert: 1971-01-01T00:00:01Z, Produktgruppe: Book, Hersteller-Nr.: biography, 1.72 k… Mehr…

Versandkosten:Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 3.00)
zuklappen (X)
3
Bestellen
bei Biblio.co.uk
$ 17,67
(ca. € 14,69)
Versand: € 10,811
Bestellen
Details beim Anbieter
gesponserter Link
Robert Charlier:
Antianginal Drugs: Pathophysiological, Haemodynamic, Methodological, Pharmacological, Biochemical and Clinical Basis for Their Use in Human Therapeutics (Handbook of Experimental Pharmacology) - Taschenbuch

2011

ISBN: 9783642651670

Springer, 2011-11-12. Softcover reprint of the origina. Paperback. Good., Springer, 2011-11-12, 2.5

Versandkosten: EUR 10.81 Ergodebooks
zuklappen (X)
4
Bestellen
bei lehmanns.de
€ 139,09
Versand: € 0,001
Bestellen
Details beim Anbieter
gesponserter Link
Robert Charlier:
Antianginal Drugs - Taschenbuch

2011, ISBN: 9783642651670

Pathophysiological, Haemodynamic, Methodological, Pharmacological, Biochemical and Clinical Basis for Their Use in Human Therapeutics, Buch, Softcover, Softcover reprint of the original 1… Mehr…

Versandkosten:Versand in 10-14 Tagen. (EUR 0.00)
zuklappen (X)
5
Bestellen
bei Biblio.co.uk
$ 16,96
(ca. € 14,10)
Versand: € 10,811
Bestellen
Details beim Anbieter
gesponserter Link
Charlier, Robert:
Antianginal Drugs: Pathophysiological, Haemodynamic, Methodological, Pharmacological, Biochemical and Clinical Basis for Their Use in Human Therapeutics (Handbook of Experimental Pharmacology) - Taschenbuch

2011, ISBN: 9783642651670

Springer, 2011-11-12. Paperback. Used:Good., Springer, 2011-11-12, 0

Versandkosten: EUR 10.81 Ergodebooks
zuklappen (X)
1Da einige Plattformen keine Versandkonditionen übermitteln und diese vom Lieferland, dem Einkaufspreis, dem Gewicht und der Größe des Artikels, einer möglichen Mitgliedschaft der Plattform, einer direkten Lieferung durch die Plattform oder über einen Drittanbieter (Marketplace), etc. abhängig sein können, ist es möglich, dass die von eurobuch angegebenen Versandkosten nicht mit denen der anbietenden Plattform übereinstimmen.

Bibliographische Daten des bestpassenden Buches

Details zum Buch
Antianginal Drugs
Autor:
Titel:
ISBN-Nummer:

3642651674


If the numerous therapeutic acquisitions of the past few years have enriched very different fields of human pathology, it does seem that coronary pathology has been given very special attention, as witness the wide variety of antianginal medications placed at the disposal of the medical profession. There are various explanations for this state of affairs, one of them probably being that the medica­ tions successively proposed do not fully satisfy the practitioner and another that the total number of individuals suffering from the clinicaI manifestations of coronary heart disease offers, by its size, a vast profit potential for the pharma­ ceuticaI industry. This field of applications opens up such prospects that it has encouraged a prolific amount of competition between various research laborato­ ries, and it is no exaggeration to say that every major firm has its individuaI anti­ anginaI drug in its therapeutic cataIogue. A further factor has aIso contributed enormously to this proliferation of medi­ cinal preparations intended for the treatment of angina pectoris: this is the rapid advance in our knowIedge of the physiopathoIogy of angina, which in turn has produced originaI concepts of pharmacological and biochemical research. As a result, there have emerged new substances whose action mechanisms have claimed to be best suited to the cardiovascular disorders responsible for cardiac pain.

Detailangaben zum Buch - Antianginal Drugs


EAN (ISBN-13): 9783642651670
ISBN (ISBN-10): 3642651674
Taschenbuch
Erscheinungsjahr: 2011
Herausgeber: Springer Berlin

Buch in der Datenbank seit 2013-01-02T09:43:26+01:00 (Berlin)
Detailseite zuletzt geändert am 2023-12-21T21:50:03+01:00 (Berlin)
ISBN/EAN: 3642651674

ISBN - alternative Schreibweisen:
3-642-65167-4, 978-3-642-65167-0
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor des Buches: robert charlier
Titel des Buches: the pharmacological basis therapeutics, the pharmacological basis therapeutic

Daten vom Verlag:

Autor/in: Robert Charlier
Titel: Handbook of Experimental Pharmacology; Antianginal Drugs - Pathophysiological, Haemodynamic, Methodological, Pharmacological, Biochemical and Clinical Basis for Their Use in Human Therapeutics
Verlag: Springer; Springer Berlin
442 Seiten
Erscheinungsjahr: 2011-11-12
Berlin; Heidelberg; DE
Gedruckt / Hergestellt in Niederlande.
Sprache: Englisch
106,99 € (DE)
109,99 € (AT)
118,00 CHF (CH)
POD
X, 442 p.

BC; Hardcover, Softcover / Medizin/Allgemeines; Medizin, allgemein; Verstehen; Drugs; drug; heart; pathology; research; Health Sciences; Pharmacy; Pharmazie, Apotheke; BB; EA

Coronary Atherosclerosis: General Considerations.- Epidemiology of Coronary Atherosclerosis.- Clinical Manifestations of Coronary Atherosclerosis.- General Therapeutic Measures in Angina Pectoris.- Physical Training in Angina Pectoris.- Treatment of Determining Factors of Atherosclerosis — of Formed Anatomical Lesions: Surgery.- — of Predisposing Factors.- — of the Anginal Syndrome.- I. Pathophysiology of Angina Pectoris.- 1. Pathophysiology of the Anginal Attack.- 2. Cardiac Dynamics during the Anginal Attack.- 3. Part Played by Hypersympathicotony in the Anginal Attack.- 4. Trends in Pharmacological Research for the Development of Antianginal Medications.- II. Haemodynamic Basis for Coronary Pharmacology.- General Considerations.- Blood Pressure.- Myocardial Oxygen Consumption.- Cardiac Work.- Cardiac Output.- Heart Rate.- Regulation of Coronary Circulation.- III. Pharmacological Methodology for Testing Antianginal Drugs.- Coronary Blood Flow.- 1. Measurement of Coronary Outflow.- 2. Measurement of Coronary Inflow.- 3. Nutritional Myocardial Micro-Circulation.- 4. Collateral Coronary Circulation.- 5. Experimental Chronic Coronary Insufficiency.- Measuring Cardiac Output.- Measuring Cardiac Work.- Measuring Myocardial Oxygen Consumption.- IV. Clinical Methods for Assessment of the Therapeutic Value of Antianginal Medications.- Diagnosis of Angina Pectoris.- Clinical Assessment of Antianginal Drugs.- V. Pharmacological and Clinical Features of Antianginal Drugs.- Nitrites.- Papaverine.- Xanthines.- Khellin.- Recordil.- Monoamineoxydase Inhibitors (Maoi).- Irrigor.- Segontin.- Amplivix.- Isoptin.- Persantine.- Intensaine.- Ustimon.- Ildamen.- Clinium.- ?-Adrenergic Blocking Drugs.- Cordarone.- Miscellaneous.- Section no. 1.- Adenylocrat.- Aminocetone.- Anginin.-Baralgin.- Baxacor.- Eucilat.- Griseofulvine.- Mederel.- Opticardon.- Pexid.- Piridoxilate.- Polarising Solutions.- Sandolanid.- Surheme.- Terodiline.- Tromcardin.- Vastarel.- Vialibran.- Section no. 2.- Morphine.- Barbiturates.- Ethyl Alcohol.- Valium.- Phenothiazines.- Diphenylhydantoin.- Cinchona Alcaloids.- Daucarine.- Vitamin E.- Hexoestrol.- Adenosine and Related Substances.- Thyroxine.- Section no. 3.- Phenoxy-Isopropyl-Norsuprifen.- Phenyl-Isobutyl-Norsuprifen.- Cyclospasmol.- Vasculat.- Reserpine.- Padutin.- Recosen.- Cortunon.- Heparin.- Dicoumarol.- Ilidar.- Priscol.- Hydergine.- Ronicol.- Poly-Methoxyphenol Derivatives.- Triparanol.- Varia.- Carotid Sinus Nerve Stimulation.- Prospects of future research.- Table of Side Effects in Man.- References.- Author Index.
< zum Archiv...